Advertisement
Advertisement

HRMY

HRMY logo

Harmony Biosciences Holdings, Inc. Common Stock

36.26
USD
Sponsored
+0.92
+2.61%
Jun 30, 11:49 UTC -4
Open

HRMY Earnings Reports

Positive Surprise Ratio

HRMY beat 15 of 23 last estimates.

65%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
$246.90M
/
$0.94
Implied change from Q1 26 (Revenue/ EPS)
+14.63%
/
+70.91%
Implied change from Q2 25 (Revenue/ EPS)
+23.15%
/
+38.24%

Harmony Biosciences Holdings, Inc. Common Stock earnings per share and revenue

On May 07, 2026, HRMY reported earnings of 0.55 USD per share (EPS) for Q1 26, missing the estimate of 0.70 USD, resulting in a -22.31% surprise. Revenue reached 215.39 million, compared to an expected 229.73 million, with a -6.24% difference. The market reacted with a -4.15% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 8 analysts forecast an EPS of 0.94 USD, with revenue projected to reach 246.90 million USD, implying an increase of 70.91% EPS, and increase of 14.63% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, Harmony Biosciences Holdings, Inc. Common Stock reported EPS of $0.55, missing estimates by -22.31%, and revenue of $215.39M, -6.24% below expectations.
The stock price moved down -4.15%, changed from $32.78 before the earnings release to $31.42 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 8 analysts, Harmony Biosciences Holdings, Inc. Common Stock is expected to report EPS of $0.94 and revenue of $246.90M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement